Investigating how tetherin enhances immune responses against HIV
Tethering lentiviral restriction to Fc-mediated antibody responses
This study is looking at how a protein called tetherin can help your immune system better fight HIV, with the hope of finding new ways to improve treatments for people living with the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10873836 on NIH RePORTER |
What this research studies
This research explores the role of a protein called tetherin in improving the immune system's ability to fight HIV. By understanding how tetherin captures HIV particles on infected cells, the study aims to enhance the effectiveness of antibody responses that can eliminate these infected cells. The researchers will investigate the mechanisms by which tetherin interacts with antibodies and how this interaction can be leveraged to improve treatments for HIV. Patients may benefit from insights that could lead to more effective therapies against HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are seeking new treatment options.
Not a fit: Patients who are not infected with HIV or those who are not responsive to antibody therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies that enhance the immune response against HIV, potentially reducing the viral load in patients.
How similar studies have performed: Previous research has shown promise in enhancing immune responses through similar mechanisms, indicating potential for success in this approach.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Evans, David T — University of Wisconsin-Madison
- Study coordinator: Evans, David T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.